4//SEC Filing
Daruwala Paul 4
Accession 0001209191-20-002030
CIK 0001610618other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 5:26 PM ET
Size
5.1 KB
Accession
0001209191-20-002030
Insider Transaction Report
Form 4
Daruwala Paul
Chief Medical Officer
Transactions
- Sale
Common Stock
2020-01-03$3.42/sh−2,340$8,003→ 53,532 total
Footnotes (1)
- [F1]Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs on 12/31/19. These sales are mandated by the Reporting Person's election to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
Documents
Issuer
Cidara Therapeutics, Inc.
CIK 0001610618
Entity typeother
Related Parties
1- filerCIK 0001639144
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 5:26 PM ET
- Size
- 5.1 KB